These results indicate that the activation of EphA1 expression promoted angiogenesis in HCC and that targeting SDF-1 might be an effective tool for inhibiting EphA1-induced HCC angiogenesis and EPC recruitment. The gene discussed is EPHA1; the disease is hepatocellular carcinoma.